Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Matsuura, Keiko ^a   Nakada, Chisato ^a   Mashio, Mizuho ^a   Narimatsu, Takahiro ^a,b   Yoshimoto, Taichiro ^a,e   Tanigawa, Masato ^a   Tsukamoto, Yoshiyuki ^a   Hijiya, Naoki ^a   Takeuchi, Ichiro ^c   Nomura, Takeo ^b   Sato, Fuminori ^b   Mimata, Hiromitsu ^b   Seto, Masao ^d   Moriyama, Masatsugu ^a,b  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Clear cell renal cell carcinoma; Hippo pathway; SAV1

Indexed keywords

MESSENGER RNA; PROTEIN; SAV1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; PHOSPHOPROTEIN; SAV1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CHROMOSOME 14Q; CLEAR CELL CARCINOMA; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; MOLECULAR MECHANICS; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 83655183227     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-523     Document Type: Article

References (30)

1. Reuter VE. The pathology of renal epithelial neoplasms. Semin Oncol 2006, 33(5):534-543. 10.1053/j.seminoncol.2006.06.009, 17045082.
2. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6(7):655-663. 10.1097/00000478-198210000-00007, 7180965.
3. Bretheau D, Lechevallier E, de Fromont M, Sault MC, Rampal M, Coulange C. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1995, 76(12):2543-2549. 10.1002/1097-0142(19951215)76:12<2543::AID-CNCR2820761221>3.0.CO;2-S, 8625083.
4. Cambell SCNA, Bukowski RM. Renal tumors. Cambell-Walsh UROLOGY 2007, 1567-1637. Philadelphia: Saunders, Wein AJ KL, Novick AC, Partin AW, Peters CA, 9.
5. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 2007, 178(2):429-434. 10.1016/j.juro.2007.03.106, 17561141.
6. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005, 23(12):2763-2771.
7. Yoshimoto T, Matsuura K, Karnan S, Tagawa H, Nakada C, Tanigawa M, Tsukamoto Y, Uchida T, Kashima K, Akizuki S, et al. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 2007, 213(4):392-401. 10.1002/path.2239, 17922474.
8. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA, Hariharan IK. salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002, 110(4):467-478. 10.1016/S0092-8674(02)00824-3, 12202036.
9. Matsuura K, Uesugi N, Hijiya N, Uchida T, Moriyama M. Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis. Hum Pathol 2007, 38(3):410-419. 10.1016/j.humpath.2006.09.006, 17239933.
10. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008, 216(4):418-427. 10.1002/path.2437, 18925646.
11. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005, 11(14):5128-5139. 10.1158/1078-0432.CCR-05-0073, 16033827.
12. Shomori K, Nagashima Y, Kuroda N, Honjo A, Tsukamoto Y, Tokuyasu N, Maeta N, Matsuura K, Hijiya N, Yano S, et al. ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas. Mod Pathol 2007, 20(2):199-207. 10.1038/modpathol.3800730, 17206105.
13. Harvey K, Tapon N. The Salvador-Warts-Hippo pathway--an emerging tumour-suppressor network. Nat Rev Cancer 2007, 7(3):182-191. 10.1038/nrc2070, 17318211.
14. Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003, 114(4):457-467. 10.1016/S0092-8674(03)00557-9, 12941274.
15. Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114(4):445-456. 10.1016/S0092-8674(03)00549-X, 12941273.
16. Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008, 20(6):638-646. 10.1016/j.ceb.2008.10.001, 18955139.
17. Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 2010, 24(9):862-874. 10.1101/gad.1909210, 2861185, 20439427.
18. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 2001, 15(10):1229-1241. 10.1101/gad.888601, 313800, 11358867.
19. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008, 22(14):1962-1971. 10.1101/gad.1664408, 2492741, 18579750.
20. Kango-Singh M, Singh A. Regulation of organ size: Insights from the Drosophila Hippo signaling pathway. Dev Dyn 2009, 238(7):1627-1637. 10.1002/dvdy.21996, 19517570.
21. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010, 24(21):2383-2388. 10.1101/gad.1978810, 2964748, 21041407.
22. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010, 19(4):491-505. 10.1016/j.devcel.2010.09.011, 3124840, 20951342.
23. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010, 107(18):8248-8253. 10.1073/pnas.0912203107, 2889558, 20404163.
24. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010, 107(4):1437-1442. 10.1073/pnas.0911427107, 2824398, 20080689.
25. Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, Lee KP, Oh HJ, Lee SH, Kong YY, Kim JM, et al. A crucial role of WW45 in developing epithelial tissues in the mouse. Embo J 2008, 27(8):1231-1242. 10.1038/emboj.2008.63, 2367404, 18369314.
26. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130(6):1120-1133. 10.1016/j.cell.2007.07.019, 2666353, 17889654.
27. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008,
28. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125(7):1253-1267. 10.1016/j.cell.2006.05.030, 3026384, 16814713.
29. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007, 21(21):2747-2761. 10.1101/gad.1602907, 2045129, 17974916.
30. Hall CA, Wang R, Miao J, Oliva E, Shen X, Wheeler T, Hilsenbeck SG, Orsulic S, Goode S. Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res 2010, 70(21):8517-8525. 10.1158/0008-5472.CAN-10-1242, 2970655, 20947521.